CareDx Price to Book Ratio 2013-2024 | CDNA

Historical price to book ratio values for CareDx (CDNA) over the last 10 years. The current price to book ratio for CareDx as of April 03, 2025 is 2.52.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

CareDx Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2025-04-04 17.28 2.50
2024-12-31 21.41 $6.91 3.10
2024-09-30 31.23 $5.15 6.07
2024-06-30 15.53 $5.03 3.09
2024-03-31 10.59 $4.95 2.14
2023-12-31 12.00 $5.07 2.36
2023-09-30 7.00 $7.28 0.96
2023-06-30 8.50 $7.50 1.13
2023-03-31 9.14 $7.83 1.17
2022-12-31 11.41 $8.05 1.42
2022-09-30 17.02 $8.16 2.09
2022-06-30 21.48 $8.32 2.58
2022-03-31 36.99 $8.62 4.29
2021-12-31 45.48 $8.80 5.17
2021-09-30 63.37 $8.95 7.08
2021-06-30 91.52 $9.13 10.02
2021-03-31 68.09 $9.08 7.50
2020-12-31 72.45 $5.62 12.90
2020-09-30 37.94 $5.47 6.94
2020-06-30 35.43 $5.34 6.64
2020-03-31 21.83 $2.36 9.26
2019-12-31 21.57 $2.33 9.26
2019-09-30 22.61 $2.30 9.83
2019-06-30 35.99 $2.20 16.34
2019-03-31 31.52 $2.28 13.82
2018-12-31 25.14 $2.32 10.85
2018-09-30 28.85 $1.14 25.21
2018-06-30 12.24 $0.80 15.21
2018-03-31 7.97 $0.95 8.41
2017-12-31 7.34 $-0.21 -35.53
2017-09-30 3.70 $-0.01 -474.36
2017-06-30 1.11 $0.56 1.98
2017-03-31 1.40 $0.70 2.01
2016-12-31 2.70 $0.93 2.91
2016-09-30 3.55 $1.73 2.05
2016-06-30 4.31 $1.72 2.51
2016-03-31 4.96 $1.71 2.90
2015-12-31 6.40 $2.48 2.58
2015-09-30 4.17 $2.85 1.46
2015-06-30 6.50 $3.11 2.09
2015-03-31 5.55 $3.34 1.66
2014-12-31 7.25 $3.50 2.07
2014-09-30 7.00 $3.48 2.01
Sector Industry Market Cap Revenue
Medical Medical Services $0.984B $0.334B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $146.516B 27.37
Elevance Health (ELV) United States $98.469B 13.19
CVS Health (CVS) United States $85.419B 12.50
Cencora (COR) United States $53.926B 19.57
DiDi Global (DIDIY) China $23.525B 0.00
Natera (NTRA) United States $19.117B 0.00
BioMerieux (BMXMF) France $14.914B 0.00
ICON (ICLR) Ireland $14.132B 12.84
Solventum (SOLV) United States $13.154B 12.27
Revvity (RVTY) United States $12.712B 21.59
Avantor (AVTR) United States $11.045B 16.21
CochLear (CHEOY) Australia $10.877B 0.00
Doximity (DOCS) United States $10.834B 56.34
EUROFINS SCIENT (ERFSF) Luxembourg $10.609B 0.00
Viatris (VTRS) United States $10.397B 3.29
Medpace Holdings (MEDP) United States $9.283B 24.12
Sonic Healthcare (SKHHY) Australia $7.768B 0.00
Charles River Laboratories (CRL) United States $7.697B 14.59
HealthEquity (HQY) United States $7.644B 37.60
Bausch + Lomb (BLCO) Canada $5.111B 23.39
Amplifon S.p.A (AMFPF) Italy $4.961B 26.19
Organon (OGN) United States $3.841B 3.91
Alignment Healthcare (ALHC) United States $3.572B 0.00
Sotera Health (SHC) United States $3.305B 19.11
BrightSpring Health Services (BTSG) United States $3.165B 32.89
Surgery Partners (SGRY) United States $3.031B 34.93
Concentras Parent (CON) United States $2.781B 14.47
GeneDx Holdings (WGS) United States $2.486B 295.22
Ardent Health Partners (ARDT) United States $1.963B 0.00
Progyny (PGNY) United States $1.908B 42.15
Agilon Health (AGL) United States $1.785B 0.00
Premier (PINC) United States $1.760B 11.27
PACS (PACS) United States $1.713B 0.00
GoodRx Holdings (GDRX) United States $1.692B 36.75
Teladoc Health (TDOC) United States $1.382B 0.00
Pediatrix Medical (MD) United States $1.243B 10.42
Establishment Labs Holdings (ESTA) $1.177B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.031B 0.00
AMN Healthcare Services Inc (AMN) United States $0.934B 7.39
Embecta (EMBC) United States $0.741B 5.08
QDM (QDMI) Hong Kong, SAR China $0.526B 13.77
Auna S.A (AUNA) Luxembourg $0.526B 13.94
Enhabit (EHAB) United States $0.444B 41.86
Sonida Senior Living (SNDA) United States $0.441B 0.00
InnovAge Holding (INNV) United States $0.403B 0.00
SBC Medicals (SBC) United States $0.329B 0.00
DocGo (DCGO) United States $0.269B 11.00
COMPASS Pathways (CMPS) United Kingdom $0.265B 0.00
Nutex Health (NUTX) United States $0.256B 5.10
LifeMD (LFMD) United States $0.243B 0.00
Performant Healthcare (PHLT) United States $0.232B 0.00
Beauty Health (SKIN) United States $0.168B 0.00
Sera Prognostics (SERA) United States $0.139B 0.00
So-Young (SY) China $0.098B 0.00
Biodesix (BDSX) United States $0.091B 0.00
Basel Medical Group (BMGL) Singapore $0.090B 0.00
OncoCyte (OCX) United States $0.088B 0.00
Oncology Institute (TOI) United States $0.086B 0.00
Ascend Wellness Holdings (AAWH) United States $0.075B 0.00
IceCure Medical (ICCM) Israel $0.065B 0.00
NeueHealth (NEUE) United States $0.056B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.026B 0.00
Pheton Holdings (PTHL) China $0.024B 0.00
ModivCare (MODV) United States $0.019B 6.57
SeaStar Medical Holding (ICU) United States $0.011B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
KindlyMD (KDLY) United States $0.010B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.001B 0.00
Aclarion (ACON) United States $0.000B 0.00
Cano Health (CANOQ) United States $0.000B 0.00